Number Risk factor (Denominator) | High-risk prescription definition (Numerator) | |
---|---|---|
PO-1 | Number of patients with a Read Code for peptic ulceration ever recorded | Number of denominator patients prescribed a traditional oral NSAID¶ or low dose aspirin in the previous eight weeks who have NOT been prescribed a gastro-protective drug in the 12 weeks before, or since the most recent NSAID or aspirin prescription |
PO-2 | Number of patients aged 75 and over | Number of denominator patients prescribed a traditional oral NSAID¶ in the previous eight weeks who have NOT been prescribed a gastro-protective drug in the 12 weeks before, or since the most recent NSAID prescription |
PO-3 | Number of patients aged 65 and over prescribed aspirin in the previous 12 weeks | Number of denominator patients prescribed a traditional oral NSAID¶ in the previous eight weeks who have NOT been prescribed a gastro-protective drug in the 12 weeks before, or since the most recent NSAID or aspirin prescription |
PO-4 | Number of patients aged 65 and over prescribed aspirin in the previous 12 weeks | Number of denominator patients prescribed clopidogrel in the previous eight weeks who have NOT been prescribed a gastro-protective drug in the 12 weeks before, or since the most recent aspirin or clopidgrel prescription |
PO-5 | Number of patients prescribed warfarin in the previous 12 weeks | Number of denominator patients prescribed a traditional oral NSAID¶ in the previous eight weeks who have NOT been prescribed a gastro-protective drug in the 12 weeks before, or since the NSAID prescription |
PO-6 | Number of patients prescribed warfarin in the previous 12 weeks | Number of denominator patients prescribed low dose aspirin or clopidogrel in the previous eight weeks who have NOT been prescribed a gastro-protective drug in the 12 weeks before, or since the aspirin or clopidogrel prescription |
PO-7 | Number of patients with a QOF heart failure code ever recorded | Number of denominator patients prescribed any oral NSAID in the previous eight weeks |
PO-8 | Number of patients prescribed both a diuretic and an ACE inhibitor/ARB in the previous 12 weeks | Number of denominator patients prescribed any oral NSAID in the previous eight weeks |
PO-9 | Number of patients with a QOF CKD (stage 3, 4, or 5) code recorded as the most recent CKD code | Number of denominator patients prescribed any oral NSAID in the previous eight weeks |
PO-10 | GI risk composite Number of patients with any risk factors as defined in PO-measures 1 to 6 | Number of denominator patients with any high-risk prescription as defined in PO-measures 1 to 6 |
PO-11 | Renal risk composite Number of patients with any risk factors in PO-measures 8 to 9 | Number of denominator patients with any high-risk prescription as defined in PO-measures 8 to 9 |